author-photo

Joakim Crona

Uppsala University Hospital

6

Papers

41

Citations

Citation Trend

Filter By

Papers (4) Sort By

Journal Conference Others

Favorable Outcome in Patients with Pheochromocytoma and Paraganglioma Treated with 177Lu-DOTATATE

2019 Cancers
Show All
- Source
- Cite
- Save
Citations (24)
Value of Tumor Growth Rate (TGR) as an Early Biomarker Predictor of Patients’ Outcome in Neuroendocrine Tumors (NET)—The GREPONET Study

2019 Oncologist
Show All
- Source
- Cite
- Save
Citations (9)
Tumour Growth Rate as a validated early radiological biomarker able to reflect treatment-induced changes in Neuroendocrine Tumours; the GREPONET-2 study.

2019 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (6)
Additional value of tumour growth rate (TGR) in patients (pts) diagnosed with well-differentiated neuroendocrine tumours (NETs) achieving RECIST-defined stable disease (SD): Subgroup analysis of the GREPONET study.

2018 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)